Comparative Study
doi: 10.1007/BF02897289.
Cytotoxicity and DNA damage caused by 4-demethoxydaunorubicin and its metabolite 4-demethoxy-13-hydroxydaunorubicin in human acute myeloid leukemia cells
Affiliations
- PMID: 2208574
- DOI: 10.1007/BF02897289
Item in Clipboard
Comparative Study
Cytotoxicity and DNA damage caused by 4-demethoxydaunorubicin and its metabolite 4-demethoxy-13-hydroxydaunorubicin in human acute myeloid leukemia cells
Cancer Chemother Pharmacol.
1990.
Abstract
4-Demethoxydaunorubicin (4-DMDR) and its major metabolite 4-demethoxy-13-hydroxydaunorubicin (4-DMDRol) were investigated for their cytotoxicity and mode of action against human leukemic cells. The drug and its metabolite appeared to be equally potent as both inhibitors of cell proliferation and inducers of DNA double-strand breaks in the OCI AML-3 cell line and cells derived directly from patients with acute myeloid leukemia (AML). This suggests that 4-DMDRol plays an important role in the antileukemic activity of 4-DMDR.
Similar articles
-
Anthracyclines and their C-13 alcohol metabolites: growth inhibition and DNA damage following incubation with human tumor cells in culture.Cancer Chemother Pharmacol. 1992;30(1):51-7. doi: 10.1007/BF00686485. Cancer Chemother Pharmacol. 1992. PMID: 1586980
-
Action mechanism of idarubicin (4-demethoxydaunorubicin) as compared with daunorubicin in leukemic cells.Int J Hematol. 1993 Apr;57(2):121-30. Int J Hematol. 1993. PMID: 8494991
-
A comparison of in vitro sensitivity of acute myeloid leukemia precursors to mitoxantrone, 4'deoxydoxorubicin, 4-demethoxydaunorubicin and daunorubicin.Leuk Res. 1986;10(12):1455-9. doi: 10.1016/0145-2126(86)90013-5. Leuk Res. 1986. PMID: 3467144
-
Regulation by retinoic acid and hydrocortisone of the anthracycline sensitivity of blast cells of acute myeloblastic leukemia.Leukemia. 1994 Dec;8(12):2065-75. Leukemia. 1994. PMID: 7807996
-
Induction of DNA damage, inhibition of DNA synthesis and suppression of c-myc expression by the anthracycline analog, idarubicin (4-demethoxy-daunorubicin) in the MCF-7 breast tumor cell line.Cancer Chemother Pharmacol. 1998;41(5):361-9. doi: 10.1007/s002800050752. Cancer Chemother Pharmacol. 1998. PMID: 9523731
Cited by
-
Anthracyclines and their C-13 alcohol metabolites: growth inhibition and DNA damage following incubation with human tumor cells in culture.Cancer Chemother Pharmacol. 1992;30(1):51-7. doi: 10.1007/BF00686485. Cancer Chemother Pharmacol. 1992. PMID: 1586980
-
Uptake and intracellular distribution of amrubicin, a novel 9-amino-anthracycline, and its active metabolite amrubicinol in P388 murine leukemia cells.Jpn J Cancer Res. 1999 Jun;90(6):685-90. doi: 10.1111/j.1349-7006.1999.tb00801.x. Jpn J Cancer Res. 1999. PMID: 10429662 Free PMC article.
-
Oral idarubicin--an anthracycline derivative with unique properties.Ann Hematol. 1993 Jan;66(1):33-43. doi: 10.1007/BF01737687. Ann Hematol. 1993. PMID: 8431520 Review.
-
Cytotoxicity of amrubicin, a novel 9-aminoanthracycline, and its active metabolite amrubicinol on human tumor cells.Jpn J Cancer Res. 1998 Oct;89(10):1067-73. doi: 10.1111/j.1349-7006.1998.tb00498.x. Jpn J Cancer Res. 1998. PMID: 9849587 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical